Brain tumors: New vaccine offers patients hope for more time
A new therapeutic vaccine for aggressive brain tumors has shown promising long-term results in a clinical study, with 66% of participants surviving eight years post-diagnosis. Unlike preventive vaccines, this therapy targets specific genetic mutations to activate the immune system against tumor cells.
Why it matters
This breakthrough offers a potential new treatment pathway for patients with historically poor prognoses for incurable brain cancers.
A new therapy offers people with seemingly incurable brain tumors scope for hope: It could slow the progression of the disease and extend patients' lives.
The report focuses on scientific findings and clinical trial data without ideological bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in